Dr. Robert Lanza Honored By BioWorld Magazine As Leader Who Could Shape Biotech Over Next 20 Years

Dr. Lanza Recognized as a “Stem Cell Pioneer”

WORCESTER, MA – May 10, 2010 (BUSINESS WIRE)—Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that the company’s Chief Scientific Officer, Robert Lanza, MD, has been recognized by BioWorld, a widely-read publication covering the biotechnology industry, as one of 28 leaders predicted to be the “movers and…

DR. LANZA RECOGNIZED AS A “STEM CELL PIONEER”

WORCESTER, MA – May 10, 2010 (BUSINESS WIRE)—Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that the company’s Chief Scientific Officer, Robert Lanza, MD, has been recognized by BioWorld, a widely-read publication covering the biotechnology industry, as one of 28 leaders predicted to be the “movers and shakers” of the biotechnology industry over the next twenty years. The story is included in the publication’s 20th anniversary issue.

The feature hails Dr. Lanza as a “stem cell pioneer,” and touches on some of his achievements at Advanced Cell Technology, including generating induced pluripotent stem (iPS) cells, as well as deriving retinal cells from human embryonic stem cells for the treatment of macular degeneration and Stargart’s disease, for which ACT filed its Investigational New Drug Application with the US Food and Drug Administration in November. Dr. Lanza is one of only six scientists to be honored, including Craig Venter, known for mapping the human genome. Other public figures recognized by the publication include Bill Gates, for his work in funding translational medical research and other projects through the Bill & Melinda Gates Foundation, and President Barack Obama, in recognition of his passage of healthcare reform legislation that provides for a pathway for regulatory approval of follow-on biologics.

“We are pleased that Dr. Lanza has been recognized for his contributions to the development of the stem cell industry,” commented William M. Caldwell IV, Chairman and CEO of ACT. “Dr. Lanza has long been a pioneer in advancing the role that human embryonic stem cells can play in treating diseases for which there is no suitable treatment, giving hope to millions who are suffering .”

To top